NCT02278744
Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery
StatusActive, Not Recruiting
PhasePhase 1
Primary completion (estimated)
At risk: Primary completion moved at least 11 months later.
See at-risk trials from Memorial Sloan Kettering Cancer Center
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 20 versions: 16 with changes below, 4 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Oct 2026 to Oct 2027
- Eligibility criteria expanded, about 8 words
- Interventions: MRI and/or CT (Device), single-fraction radiation (Radiation) to MRI and/or CT (Device), single-fraction radiation (Radiation)
- Secondary endpoints: details revised at 2 of 2 entries
- Notable Primary and study completion dates: Oct 2025 to Oct 2026v19
- Notable Primary and study completion dates: Oct 2024 to Oct 2025v17
- Notable Primary and study completion dates: Oct 2023 to Oct 2024v16
- Notable Primary and study completion dates: Oct 2022 to Oct 2023v15
Show 10 earlier versionsHide 10 earlier versions
- Minor Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 18 to confirmed 9
- Start date: Oct 2014 to Oct 27, 2014
- Site details revised
- Notable Primary and study completion dates: Oct 2021 to Oct 2022v12
- Notable Primary and study completion dates: Oct 2019 to Oct 2021v10
- Notable Primary and study completion dates: Oct 2018 to Oct 2019v9
- Notable Primary completion date: Oct 2017 to Oct 2018
- Study completion date: Oct 2018
- Notable Eligibility criteria shortened, about 52 wordsv6
- Notable Eligibility criteria expanded, about 14 words
- Interventions: MRI or CT (Device), single-fraction radiation (Radiation) to MRI and/or CT (Device), single-fraction radiation (Radiation)
- Notable Primary completion date: Oct 2016 to Oct 2017v4
- Notable Eligibility criteria expanded, about 2 words
- Interventions: MRI (Device), single-fraction radiation (Radiation) to MRI or CT (Device), single-fraction radiation (Radiation)
- Notable Eligibility criteria expanded, about 28 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
toxicities as measured by the National Cancer Institute (NCI) Common Toxicity Criteria
Timeframe: 1 year
Secondary (2)
local failure
overall survival
Arms and interventions
single-fraction radiosurgeryExperimental
Radiation: single-fraction radiation
Devices: MRI and/or CT
Sites
1 site in 1 country
- Memorial Sloan Kettering Cancer CenterNew York, New York, United States